Robert James Holt

Title: Exploring the Contributions of Inventor Robert James Holt

Introduction

Robert James Holt, based in Knutsford, GB, is an innovative mind in the field of biomedical research, specifically focusing on colon cancer diagnostics. With his significant contributions, he has made notable advancements in understanding and diagnosing colon cancer through genetic signatures.

Latest Patents

Robert Holt holds one patent titled "Colon cancer gene expression signatures and methods of use." This patent presents a gene expression signature of colon cancer, detailing microarrays that include such signatures, as well as methods for leveraging this information. The gene expression signature is particularly valuable for ascertaining the prognosis of individuals diagnosed with colon cancer, notably stage II. This innovation is crucial for evaluating the effectiveness of surgical resection and chemotherapy, as well as predicting potential cancer recurrence in patients.

Career Highlights

Currently affiliated with Almac Diagnostics Limited, Robert Holt has distinguished himself within the realm of genetic research and cancer diagnostics. His expertise and work have provided deeper insights into the prognostic evaluation of colon cancer patients, positioning him as a notable figure within his field.

Collaborations

Throughout his career, Robert has collaborated with esteemed colleagues, including Denis Paul Harkin and Vitali Proutski. Together, they have furthered advancements in genetic research, contributing to improved treatment strategies and patient outcomes in the realm of colon cancer.

Conclusion

Robert James Holt's innovative contributions, particularly his patent on colon cancer gene expression signatures, underscore the importance of genetic research in enhancing diagnostic and therapeutic methods for cancer. His work at Almac Diagnostics Limited and collaborations with fellow researchers demonstrate a commitment to improving patient care through scientific innovation.